This beginner’s guide explains how to buy Snorter Bot tokens at presale prices. Learn how to participate in the presale in under 5 minutes. Snorter Bot (SNORT) is an advanced Telegram-based trading ...

Welcome to the Solana Trading Bot! This project allows you to build and run your very own Telegram trading bot for the Solana blockchain. Whether you're completely new to programming or just starting ...

Dara-Abasi Ita writes about trading and investing for Investopedia and Investing.com, and he is an editor at Lawverse magazine. He has written about financial topics, including private equity, asset ...

AI crypto trading bots are becoming game-changers for investors who want to be more efficient and accurate in the evolving world of digital assets. These smart systems use AI to automate trades, ...

Kraken acquires Capitalise.ai to launch no-code trading on Kraken Pro. Natural-language trading tools coming soon to Kraken Pro via Capitalise.ai. No-code strategies land on Kraken Pro after ...

Spotware, the developer of the cTrader multi-asset trading platform has launched an essential update with the introduction of cTrader Windows version 5.4, native Python, supporting algorithmic trading ...

We sometimes use affiliate links in our content, when clicking on those we might receive a commission – at no extra cost to you. By using this website you agree to our terms and conditions and privacy ...

Cybersecurity firm SentinelLABS has warned that malicious actors are using old, seemingly legitimate YouTube accounts to promote a crypto trading bot that hides a smart contract designed to drain ...

17-year-old Nathan Smith made ChatGPT help him pick micro stocks and documented his open-source AI experiment on Substack and GitHub. Wall Street firms are quietly rolling out their own AI copilots, ...

Portfolio trading volumes in US corporate bonds jumped 54% in the first half of 2025 to a record US$823bn, according to Barclays, in the latest sign of how technology is fast reshaping credit markets ...

Alex Carchidi is a contributing Motley Fool healthcare and cryptocurrency analyst covering biotech, pharma, cannabis, and digital asset companies. Previously, Alex was a bench scientist and science ...